Role of K63-linked ubiquitination in cancer

L Cao, X Liu, B Zheng, C Xing, J Liu - Cell death discovery, 2022 - nature.com
Ubiquitination is a critical type of post-translational modifications, of which K63-linked
ubiquitination regulates interaction, translocation, and activation of proteins. In recent years …

The love-hate relationship between TGF-β signaling and the immune system during development and tumorigenesis

B Chen, C Mu, Z Zhang, X He, X Liu - Frontiers in immunology, 2022 - frontiersin.org
Since TGF-β was recognized as an essential secreted cytokine in embryogenesis and adult
tissue homeostasis a decade ago, our knowledge of the role of TGF-β in mammalian …

Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway

G Chen, H Zhang, H Sun, X Ding, G Liu, F Yang… - Apoptosis, 2023 - Springer
Gastric cancer (GC) is the most common malignant tumor of digestive system. Bufalin
extracted from Venenum Bufonis is one of the most effective anticancer monomers, which …

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging‐related diseases

T Xia, Y Zhou, J An, Z Cui, X Zhong, T Cui, B Lv… - Aging …, 2024 - Wiley Online Library
CD4+ T cells play a notable role in immune protection at different stages of life. During
aging, the interaction between the body's internal and external environment and CD4+ T …

Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer

L Niu, Y Liu, N Li, Y Wang, L Kang, X Su, C Xu… - International Journal of …, 2024 - Elsevier
Transforming growth factor β (TGF-β), a versatile immunosuppressive cytokine, has gained
increasing attention as a potential target for cancer immunotherapy. However, current …

Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets

Z Hong, F Liu, Z Zhang - Experimental Hematology & Oncology, 2024 - Springer
Although immune checkpoint-based cancer immunotherapy has shown significant efficacy
in various cancers, resistance still limits its therapeutic effects. Ubiquitination modification is …

The emerging role of IL-9 in the anticancer effects of anti-PD-1 therapy

D Vinokurova, L Apetoh - Biomolecules, 2023 - mdpi.com
PD-1 blockade rescues failing anticancer immune responses, resulting in durable
remissions in some cancer patients. Cytokines such as IFNγ and IL-2 contribute to the anti …

Age-related decline in CD8+ tissue resident memory T cells compromises antitumor immunity

S Pei, X Deng, R Yang, H Wang, JH Shi, X Wang… - Nature Aging, 2024 - nature.com
Aging compromises antitumor immunity, but the underlying mechanisms remain elusive.
Here, we report that aging impairs the generation of CD8+ tissue resident memory T (TRM) …

[HTML][HTML] Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors

T Chen, Y Xue, S Wang, J Lu, H Zhou, W Zhang… - Bioactive Materials, 2023 - Elsevier
Insufficient infiltration of T cells severely compromises the antitumor efficacy of adoptive cell
therapy (ACT) against solid tumors. Here, we present a facile immune cell surface …

[HTML][HTML] Single-cell and bulk sequencing analyses reveal the immune suppressive role of PTPN6 in glioblastoma

X Zhang, J Chen, M Zhang, S Liu, T Wang, T Wu… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is a highly malignant brain cancer with a poor prognosis despite
standard treatments. This investigation aimed to explore the feasibility of PTPN6 to combat …